June 2019
European Radiology Profiles Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology
Seno Medical’s opto-acoustic technology could reduce false positives and identify cancer sub-types
SAN ANTONIO, June 19, 2019 /PRNewswire/ — Additional research appearing in the June online issue (open access) of European Radiology features the groundbreaking diagnostic breast […]
May 2019
Seno Medical and “Know Your Lemons” Team Up For Breast Cancer Education
Partnership emphasizes breast health education and empowers women
SAN ANTONIO, May 12, 2019 – Seno Medical Instruments, Inc. (Seno Medical), a Texas-based medical imaging company developing breakthrough breast cancer diagnostic technology, […]
January 2019
Multiple Publications and Presentations Underscore Seno Medical’s Value Proposition in Mitigating the Cost and Burden of Unnecessary Breast Biopsies
SAN ANTONIO, January 8, 2019 – Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today provided a summary of key 2018 data […]
December 2018
New Data Demonstrate That Seno Medical’s Opto-Acoustic Imaging Technology Offers A Non-Invasive Approach to Differentiating Breast Cancer Molecular Subtypes
– Company’s technology, which shows promise as a clinical prognostic tool that may facilitate treatment decisions, featured as a High Impact Clinical Trial at the Radiological Society of North America Annual Meeting for second year in a row –
SAN ANTONIO, […]
November 2018
Seno Medical: Making a Difference for Breast Cancer in San Antonio
– San Antonio-based technology company focuses on improving breast cancer diagnostic accuracy and ‘walking the talk’ inside the company –
SAN ANTONIO, November 12, 2018 – Local diagnostic imaging system developer, Seno Medical, is taking a serious stance against breast cancer. Not […]
May 2018
Annual Cost of False-Positive Breast Biopsies Exceeds $2 Billion According to Recent Study
– Publication in ClinicoEconomics and Outcomes Research estimates nearly $8 billion annually in expense for additional breast diagnostic testing, underscoring market need for improved breast diagnostic tools –
SAN ANTONIO, May 31, 2018 – False-positive breast biopsies in the United States cost […]
In the News
View featured storiesView featured stories
Media Kit
View Media KitView Media Kit
Sign Up
Receive updates when we post a new press release.Sign up to receive updates when we post a new press release.